HeartBeam, Inc. (BEAT)

Market Cap	58.33M
Revenue (ttm)	n/a
Net Income (ttm)	-14.64M
Shares Out	26.39M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,432
Open	2.250
Previous Close	2.200
Day's Range	2.060 - 2.290
52-Week Range	1.060 - 3.740
Beta	-1.22
Analysts	Strong Buy
Price Target	6.78 (+206.79%)
Earnings Date	May 9, 2024

About BEAT

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 15
• Stock Exchange: NASDAQ
• Ticker Symbol: BEAT

Analyst Forecast

According to 2 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price forecast is $6.78, which is an increase of 206.79% from the latest price.

Price Target

$6.78

(206.79% upside)

Analyst Consensus: Strong Buy